{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T21:17:22Z","timestamp":1770931042452,"version":"3.50.1"},"reference-count":140,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Patents"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1517\/13543776.2014.895325","type":"journal-article","created":{"date-parts":[[2014,3,7]],"date-time":"2014-03-07T09:50:14Z","timestamp":1394185814000},"page":"555-572","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of patents on anti-gout therapies issued in China"],"prefix":"10.1517","volume":"24","author":[{"given":"Hong-Yu","family":"Yuan","sequence":"first","affiliation":[{"name":"Nanjing Medical University, The First Affiliated Hospital, Research Division of Clinical Pharmacology","place":["China"]},{"name":"Jiangsu Shengze Hospital, Department of Pharmacology","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jiangsu Shengze Hospital, Department of Pharmacology","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jiangsu Shengze Hospital, Department of Pharmacology","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Fu","family":"Wei","sequence":"additional","affiliation":[{"name":"Nanjing Medical University, The First Affiliated Hospital, Research Division of Clinical Pharmacology","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Meng","sequence":"additional","affiliation":[{"name":"Nanjing Medical University, The First Affiliated Hospital, Research Division of Clinical Pharmacology","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,3,7]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-143-7-200510040-00009"},{"key":"e_1_3_2_4_1","first-page":"359","article-title":"Approach to the treatment of hyperuricemia","volume":"92","author":"Poon SH","year":"2009","unstructured":"Poon SH, Hall HA, Zimmermann B. Approach to the treatment of hyperuricemia. Med Health R I 2009;92:359-62","journal-title":"Med Health R I"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S6048"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar4281"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21824"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.cco.0000152664.87204.3c"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3272"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.076232"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096693"},{"key":"e_1_3_2_12_1","first-page":"159","article-title":"Treatment of hyperuricemia and gout","volume":"28","author":"Grobner W","year":"2005","unstructured":"Grobner W, Walter-Sack I. Treatment of hyperuricemia and gout. Med Monatsschr Pharm 2005;28:159-64","journal-title":"Med Monatsschr Pharm"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543776.2011.577417"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60665-4"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-200027372"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221307779815020"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/2040622312462056"},{"key":"e_1_3_2_18_1","first-page":"44","article-title":"Research progress of Chinese medicine treatment of gout","volume":"4","author":"Liu YF","year":"2012","unstructured":"Liu YF, Xu SH. Research progress of Chinese medicine treatment of gout. Chin Western Med 2012;4:44-7","journal-title":"Chin Western Med"},{"key":"e_1_3_2_19_1","first-page":"204","article-title":"Progress in treatment of acute gouty arthritis by traditional Chinese medicine","volume":"8","author":"Fu DH","year":"2013","unstructured":"Fu DH, Zhang XQ, Liu ZQ, et al. Progress in treatment of acute gouty arthritis by traditional Chinese medicine. World J Integr Tradit Western Med 2013;8:204-6","journal-title":"World J Integr Tradit Western Med"},{"key":"e_1_3_2_20_1","first-page":"252","article-title":"Literature research of traditional Chinese medical prescriptions of gout in lntermission and chronic phase","volume":"31","author":"Li HC","year":"2013","unstructured":"Li HC, Wen CP, Xie ZJ, et al. Literature research of traditional Chinese medical prescriptions of gout in lntermission and chronic phase. Chin Arch Tradit Chin Med 2013;31:252-5","journal-title":"Chin Arch Tradit Chin Med"},{"key":"e_1_3_2_21_1","first-page":"666","article-title":"Meta-analysis on clinical therapeutic Effects of TCM on Gout","volume":"29","author":"Yuan HY","year":"2011","unstructured":"Yuan HY, He M, Ou N. Meta-analysis on clinical therapeutic Effects of TCM on Gout. Chin Arch Tradit Chin Med 2011;29:666-70","journal-title":"Chin Arch Tradit Chin Med"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/10572317.2004.10762642"},{"key":"e_1_3_2_23_1","first-page":"403","article-title":"Recent advancesin novel non-purine selective inhibitors of xanthine oxidase for the treatment of hyperuricemia and gout","volume":"22","author":"Zhan P","year":"2012","unstructured":"Zhan P, Lin T, Lin XY. Recent advancesin novel non-purine selective inhibitors of xanthine oxidase for the treatment of hyperuricemia and gout. Chin J Med Chem 2012;22:403-15","journal-title":"Chin J Med Chem"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2012.05.004"},{"key":"e_1_3_2_25_1","volume-title":"Formula of traditional chinese medicine","author":"Li J","year":"2006","unstructured":"Li J. Formula of traditional chinese medicine. China Press of Traditional Chinese Medicine, Beijing; 2006"},{"key":"e_1_3_2_26_1","first-page":"440","article-title":"Forty-two patients with acute gouty arthritis treated by zhitongrushen decoction","volume":"31","author":"Jia W L","year":"2010","unstructured":"Jia W L. Forty-two patients with acute gouty arthritis treated by zhitongrushen decoction. Shaanxi J Tradit Chin 2010;31:440-1","journal-title":"Shaanxi J Tradit Chin"},{"key":"e_1_3_2_27_1","first-page":"9","article-title":"Professor YANG Zhen-guo Zhubai Tongfeng Soup treat Cure Gout 52 cases","volume":"25","author":"Huang LJ","year":"2011","unstructured":"Huang LJ, Chen YS. Professor YANG Zhen-guo Zhubai Tongfeng Soup treat Cure Gout 52 cases. J Pract Tradit Chin Intern Med 2011;25:9-10","journal-title":"J Pract Tradit Chin Intern Med"},{"key":"e_1_3_2_28_1","first-page":"1914","article-title":"Clinical and experimental study on the effect of complex gout capsule on gout","volume":"20","author":"Li CR","year":"2009","unstructured":"Li CR, Li DL, Zhou JG, et al. Clinical and experimental study on the effect of complex gout capsule on gout. Lishizhen Med Mater Med Res 2009;20:1914-15","journal-title":"Lishizhen Med Mater Med Res"},{"key":"e_1_3_2_29_1","first-page":"474","article-title":"Clinical observation on treating 30 cases of acute gouty arthritis by gout mixture","volume":"21","author":"Yang CQ","year":"2006","unstructured":"Yang CQ, Cao KG. Clinical observation on treating 30 cases of acute gouty arthritis by gout mixture. China J Tradit Chin Med Pharm 2006;21:474-5","journal-title":"China J Tradit Chin Med Pharm"},{"key":"e_1_3_2_30_1","unstructured":"Zhang J. Treatment of gout hyperuricemia and hyperlipidemia drugs and preparation methods. CN200410052357. 0; 2004"},{"key":"e_1_3_2_31_1","unstructured":"Zhang XH Lv WY. A drug and preparation for the treatment of gout. CN201010266469. 1; 2010"},{"key":"e_1_3_2_32_1","unstructured":"Zhou GS. Gout pill. CN201110115642. 2; 2011"},{"key":"e_1_3_2_33_1","first-page":"60","article-title":"Qingxiao Zhitong powder on the treatment of 50 cases of gouty arthritis","volume":"16","author":"Zhang H","year":"2009","unstructured":"Zhang H, Gao F, Xiao L. Qingxiao Zhitong powder on the treatment of 50 cases of gouty arthritis. Chin J Inform Tradit Chin Med 2009;16:60","journal-title":"Chin J Inform Tradit Chin Med"},{"key":"e_1_3_2_34_1","unstructured":"Yan CP. Ointment and preparation methods for the treatment of gout. CN201110103763. 2; 2011"},{"key":"e_1_3_2_35_1","unstructured":"Zhu Q. Topical preparations of Chinese medicine and its preparation method for the treatment of gout. CN200410040457.1; 2004"},{"key":"e_1_3_2_36_1","unstructured":"Wang ZH. Traditional Chinese medicine wine for external use the treatment of gout. CN200410036755.3; 2004"},{"key":"e_1_3_2_37_1","unstructured":"Li XX. A kind of oral traditional Chinese medicine combination for the treatment of gout. CN01010261882.9; 2010"},{"key":"e_1_3_2_38_1","unstructured":"You DS. New use of the traditional Chinese medicine water willow. CN200610010739.6; 2006"},{"key":"e_1_3_2_39_1","unstructured":"Yuan HY Ou N Wang LB et al. Gnetum effective part preparation method and application in preparation for anti- gout drug. CN200910032924.9; 2009"},{"key":"e_1_3_2_40_1","unstructured":"Ai S Xu W Wu T et al. Methods the anti-inflammatory effective parts extracted from Capparis spinosa. CN200310113957.9; 2003"},{"key":"e_1_3_2_41_1","unstructured":"Zhao J Zhao XQ. The use of steroid saponins compounds and their derivatives in the preparation of drug for treatment of purine metabolic disorders. CN200910094378.1; 2009"},{"key":"e_1_3_2_42_1","first-page":"721","article-title":"Research progress of hyperuricemia and gout in prevention of flavonoids compounds","volume":"44","author":"Xia DZ","year":"2009","unstructured":"Xia DZ, Zhang Y, Lv GY. Research progress of hyperuricemia and gout in prevention of flavonoids compounds. Chin Pharm J 2009;44:721-3","journal-title":"Chin Pharm J"},{"key":"e_1_3_2_43_1","unstructured":"Huo RH Li LF Guo SY et al. An application of flavone in the preparation of excretion uricosuric drugs. CN200510085043.5; 2005"},{"key":"e_1_3_2_44_1","unstructured":"Qiu ZD Qu XB Shui DJ et al. Corn silk extract and preparation method and application in preparation for treating gout drug. CN200810051485.1; 2008"},{"key":"e_1_3_2_45_1","unstructured":"Chen HS Qiao LM Lin JG et al. Celery seed flavonoids and coumarins compounds application in the preparation drug for the prevention and treating of anti-gout. CN200710062800.6; 2007"},{"key":"e_1_3_2_46_1","unstructured":"Kong LD Yang C Bao JW et al. Mulberry extract extraction methods and uses. CN02113004.3; 2002"},{"key":"e_1_3_2_47_1","unstructured":"Zhang Y Lu BY Wu XQ et al. The application of the extracts from the plum tree(non fruit). CN200610118773.5; 2006"},{"key":"e_1_3_2_48_1","unstructured":"Wen RL. Phloridzin in the preparation of the application of hyperuricemia drug treatment. CN201010246209.8; 2010"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1185521"},{"key":"e_1_3_2_50_1","unstructured":"Zhao Y Bai H. A class of cinnamon alcohol derivatives its preparation method and drug use. CN200910142064.4; 2009"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11418-009-0331-y"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2004.03.037"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2004.pto940506.x"},{"key":"e_1_3_2_54_1","unstructured":"Zhao Y Gong JM Liu GM. A class silybin derivatives of the E ring substituted and its preparation. CN201010117295.2; 2010"},{"key":"e_1_3_2_55_1","unstructured":"Huang KX Wang F Li XA et al. Ethyl malonyl silibinin derivatives were used for the preparation of antioxidant drug use. CN200910096290.3; 2009"},{"key":"e_1_3_2_56_1","unstructured":"Zhao Y Wang F Liu GM et al. A method for preparing A ring to replace silybin ether and their medical application. CN200910099042.4; 2009"},{"key":"e_1_3_2_57_1","unstructured":"Yang DJ Zhong GY Xu JH et al. The application of puerarin and its derivatives in pharmacy. CN200810069880.2; 2008"},{"key":"e_1_3_2_58_1","unstructured":"Bai L Song LY Lei T et al. Quercetin dimers flavonoids was used to prepare antioxidant drug use. CN201010181800.X; 2010"},{"key":"e_1_3_2_59_1","unstructured":"Fen FJ Wang WY Yu JP et al. A kind for prevention and treatment of gout and hyperuricemia drugs. CN200610091089.2; 2006"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.09.076"},{"key":"e_1_3_2_61_1","unstructured":"Shui Q Wang XM Wang ZF et al. 2-(3-cyano-4- isobutyl-phenyl)-4- methyl-5- thiazole formic acid crystal form and preparation method. CN200610030935.X0; 2006"},{"key":"e_1_3_2_62_1","unstructured":"Shui Q Wang XM Wang ZF et al. Febuxostat crystal form and preparation methods. CN200710047268.0; 2007"},{"key":"e_1_3_2_63_1","unstructured":"Shui Q Wang XM Wang ZF et al. 2-(3-cyano-4- isobutyl-phenyl)-4- methyl-5- thiazole formic acid crystal form and preparation method. CN201010003140.6.X 0; 2006"},{"key":"e_1_3_2_64_1","unstructured":"Zhang JQ Wang N Zhao CJ et al. Urate oxidase lipid nanoparticles and preparation methods. CN200910103269.1; 2009"},{"key":"e_1_3_2_65_1","unstructured":"Li JM Hao B Yang JT et al. The treatment of acute gout colchicine transdermal absorption patch and its preparation method. CN200710057506.6; 2007"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2013.05.002"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.2174\/187221307779815020"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208307200"},{"key":"e_1_3_2_69_1","unstructured":"Shiguan ZG Shenben HS Fuchen J et al. 1- phenyl pyrazole compounds and pharmaceutical applications. CN97180548.2; 1997"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2010.02.013"},{"key":"e_1_3_2_71_1","unstructured":"Kawakami M Tokoro M Ikeda K et al. Therapeutic agent for hypertension. WO2008126772A1; 2008"},{"key":"e_1_3_2_72_1","unstructured":"MIyata J Yokota M Naito R et al. 2-phenyl-thiophene derivative. WO2006022375A1; 2006"},{"key":"e_1_3_2_73_1","unstructured":"Miyata J Naito R Kawakami M et al. 2-phenyl pyridine derivatives. CN200580028792.2; 2005"},{"key":"e_1_3_2_74_1","unstructured":"Nakamura H Kaneda S Sato T et al. New 1 2 4 - triazole compounds. CN02819276.1; 2002"},{"key":"e_1_3_2_75_1","unstructured":"Ishibuchi S Morimoto H Inoue H et al. 1-phenyl pyrazole compounds and pharmaceutical applications. CN97180548.2; 1997"},{"key":"e_1_3_2_76_1","unstructured":"Zhao Y Wang F Bai H. 3-(3-nitro-4-hydroxy)-ethyl acrylate inhibition of xanthine oxidase medicinal use. CN200610090013.8; 2006"},{"key":"e_1_3_2_77_1","unstructured":"Qi YM Jie Q Zhang FM. Inhibit the xanthine oxidase activity of aromatic nitrile thiazole derivatives preparation method and use. CN200810121654.4; 2008"},{"key":"e_1_3_2_78_1","unstructured":"Feng MS Cao YZ Yao QZ et al. 2-aryl-thiazole derivatives and pharmaceutical compositions thereof. CN200910033852.X; 2009"},{"key":"e_1_3_2_79_1","unstructured":"Wang CL Li YD Chen MH et al. Arachidonic acid as xanthine oxidase inhibitor use and in the preparation of the treatment for hyperuricemia or gout drug. CN201110008531.1; 2011"},{"key":"e_1_3_2_80_1","unstructured":"Li L Zhu HJ Zhu YF et al. Compound 3 5 2 4 - tetrahydroxy chalcone as preparation for the prevention and control of hyperuricemia and gout. CN201010144406.9; 2010"},{"key":"e_1_3_2_81_1","unstructured":"Zhu X Jiang XM Zhang YG et al. The preparation method of the Febuxostat intermediates. CN200910035373.1; 2009"},{"key":"e_1_3_2_82_1","unstructured":"Zhou QG. The preparation method of the febuxostat intermediates. CN201010543350.4; 2010"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2012.02.009"},{"key":"e_1_3_2_84_1","first-page":"651","article-title":"Benzbromarone with drawn from the European market: another case of \"absence of evidence is evidence of absence\"?","volume":"22","author":"Jansen TL","year":"2004","unstructured":"Jansen TL, Reinders MK, Van-Roon EN, et al. Benzbromarone with drawn from the European market: another case of \"absence of evidence is evidence of absence\"? Clin Exp Rheumatol 2004;22:651","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_2_85_1","first-page":"41","article-title":"Clinical observation of losartan in treatment of hypertension complicated with hyperuricemia","volume":"28","author":"Xu WH","year":"2001","unstructured":"Xu WH, Zhang SP, Xiao JY, et al. Clinical observation of losartan in treatment of hypertension complicated with hyperuricemia. Foreign Med Sci (Section of Cardiovascular Disease) 2001;28:41-3","journal-title":"Foreign Med Sci (Section of Cardiovascular Disease)"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1021\/jm1015022"},{"key":"e_1_3_2_87_1","unstructured":"O'Neil JD Sharma S Ramachandran A. Tetrazole compounds for reducing uric acid. CN200980115547.3; 2009"},{"key":"e_1_3_2_88_1","unstructured":"Wang SJ Zhang TJ. 2-ethyl-3-(4- hydroxyl) benzoyl benzofuran compounds compositions and methods of preparation. CN201210167867.7; 2012"},{"key":"e_1_3_2_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-2697(02)00293-2"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2005.07.056"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.molbev.a004123"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1970.tb00813.x"},{"key":"e_1_3_2_93_1","first-page":"398","article-title":"Efficacy and safety of Lesinurad (RDEA594), a novel uricosuric agent, given in combination with allopurinol refractory gout patients: rando-mized, double-blind, placebo-controlled, phase 2b study","volume":"63","author":"Perez-Ruiz F","year":"2011","unstructured":"Perez-Ruiz F, Sundy J, Krishnan E, et al. Efficacy and safety of Lesinurad (RDEA594), a novel uricosuric agent, given in combination with allopurinol refractory gout patients: rando-mized, double-blind, placebo-controlled, phase 2b study. Arthritis Rheum 2011;63:398-9","journal-title":"Arthritis Rheum"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.3.697"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-007-0041-y"},{"key":"e_1_3_2_96_1","unstructured":"Liu GA Yang Z Lin QH et al. Pegylated uricoxidase compound its preparation method its preparation and Application. CN200710068506.6; 2007"},{"key":"e_1_3_2_97_1","unstructured":"Fan K Zhang C Ma XF. Humanized recombinant uricase and its mutants. CN200910191240.3; 2009"},{"key":"e_1_3_2_98_1","unstructured":"Wu YZ Xu MB Chen Y. A method for preparation of restructuring candida urate oxidase. CN03109150.4; 2003"},{"key":"e_1_3_2_99_1","unstructured":"Ensor CM Clark MA Holtzberg FW. PEG modification of urate oxidase. CN02819387.3; 2002"},{"key":"e_1_3_2_100_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400525"},{"key":"e_1_3_2_101_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2143"},{"key":"e_1_3_2_102_1","unstructured":"Ottosen ER Rachlin S. As interleukin and TNF inhibitors amino diacetone. CN98802830.1; 1998"},{"key":"e_1_3_2_103_1","unstructured":"Han SH. New uses of bacterial lipopolysaccharide. CN200910226694.X; 2009"},{"key":"e_1_3_2_104_1","unstructured":"Miao ZM Li CG Wang YL. 5\u2032-AMP for the treatment of gouty arthritis. CN201010261859.X; 2010"},{"key":"e_1_3_2_105_1","unstructured":"Gao YX Han JX Li HZ. Novel 2-oxo heterocyclic compounds and containing the compounds pharmaceutical compositions. CN200480013231.0; 2004"},{"key":"e_1_3_2_106_1","unstructured":"Gaul M Searle LL Rentzeperis D. As estrogen related receptor modulator to replace the phenoxy N - alkylation of thiazolidinedione. CN200880015361.6; 2008"},{"key":"e_1_3_2_107_1","unstructured":"End DW Cools MLL Van Wauwe JPF. Farnesyl protein transferase inhibitors for treating arthropathies. CN99808311.9; 1999"},{"key":"e_1_3_2_108_1","unstructured":"Bombardelli E Fontana G. Colchicine nucleoside analogues. CN200480015665.4; 2004"},{"key":"e_1_3_2_109_1","unstructured":"Chinese Pharmacopoeia Commission. Chinese Pharmacopoeia 2010 Edition(a). China Press of Traditional Chinese Medicine Beijing; 2010"},{"key":"e_1_3_2_110_1","unstructured":"Liu GM. Combinations of synthetic compounds and traditional Chinese medicines for treating gout. CN200710077710.4; 2007"},{"key":"e_1_3_2_111_1","unstructured":"Li CP. A medicinal combination for the treatment of gout. CN200910016369.0; 2009"},{"key":"e_1_3_2_112_1","volume-title":"Science of Chinese materia medica [M]","author":"Gao XM","year":"2006","unstructured":"Gao XM. Science of Chinese materia medica [M]. China Press of Traditional Chinese Medicine, Beijing; 2006"},{"key":"e_1_3_2_113_1","unstructured":"Li L Chen ZH. New use of mangiferin compounds. CN200810058019.6; 2008"},{"key":"e_1_3_2_114_1","unstructured":"Wu HP Ha TZ Zhang Z et al. The application of Caulis Polygoni Multiflori. CN201010214582.5; 2010"},{"key":"e_1_3_2_115_1","unstructured":"Wu HP Chen MJ Xu TT et al. Inhibition of alpha glucosidase and xanthine oxidase activity of extracts from traditional Chinese medicine preparation method and application. CN201010219609.X; 2010"},{"key":"e_1_3_2_116_1","unstructured":"Lian Y Yang YH Wang MY. Syringin in the preparation of the application for treatment of acute gout drug. CN201010263542.X; 2010"},{"key":"e_1_3_2_117_1","unstructured":"Wang CL Qi X Chen MH. Use vegetable extracts inhibited xanthine oxidase and in the preparation for the prevention and treatment of Hyperuricemia or gout in food applications. CN201110026446.8; 2011"},{"key":"e_1_3_2_118_1","unstructured":"Chen J Li P Gao W. Salvianolic acid C application in the preparation of the prevention and treatment of hyperuricemia drugs. CN201210000772.6; 2012"},{"key":"e_1_3_2_119_1","unstructured":"Chen ZH. Leaf extract of Herba Siegesbeckiae preparation method and application thereof. CN200710170657; 2007"},{"key":"e_1_3_2_120_1","unstructured":"Chen GH. Pandan leaf extract in the treatment of gout and its preparation method. CN200810066408.3; 2008"},{"key":"e_1_3_2_121_1","unstructured":"Zhang TM Sun XB. Frankincense in preparation for the treatment of gout drug use. CN200510021019.5; 2005"},{"key":"e_1_3_2_122_1","unstructured":"Zhang B Liu XQ Sa Y et al. The new use water extract of chicory. CN200510021019.5; 2005"},{"key":"e_1_3_2_123_1","unstructured":"Zhang B Liu XQ Lin ZJ et al. Chicory or Jerusalem artichoke effective parts and its preparations. CN200910089644.1; 2009"},{"key":"e_1_3_2_124_1","unstructured":"Song Y Sheng R Tan J et al. The new use of Fructus Evodiae Rutaecarpae and its extract. CN201010124121.9; 2010"},{"key":"e_1_3_2_125_1","unstructured":"Yu HW Ma YR. Pennycress total extraction method and its medicinal use. CN201010503873.6; 2010"},{"key":"e_1_3_2_126_1","first-page":"241","article-title":"Effect of radix puerariae extracts on acute gouty arthritis and its mechanisms","volume":"22","author":"Ma Y","year":"2011","unstructured":"Ma Y, Lv GY, Chen SH. Effect of radix puerariae extracts on acute gouty arthritis and its mechanisms. Tradit Chin Drug Res Clin Pharmacol 2011;22:241-4","journal-title":"Tradit Chin Drug Res Clin Pharmacol"},{"key":"e_1_3_2_127_1","first-page":"21","article-title":"Analysis and mechanism of Polygonum cuspidatum extract on experimental gout","volume":"8","author":"Lin J C","year":"2012","unstructured":"Lin J C. Analysis and mechanism of Polygonum cuspidatum extract on experimental gout. Asia-Pacific Tradit Med 2012;8:21-2","journal-title":"Asia-Pacific Tradit Med"},{"key":"e_1_3_2_128_1","first-page":"76","article-title":"Effects of Polygonum cuspidatum extract on acute gouty arthritis induced by sodium urate rabbit synovial tissue PPAR-C","volume":"26","author":"Hou J P","year":"2010","unstructured":"Hou J P. Effects of Polygonum cuspidatum extract on acute gouty arthritis induced by sodium urate rabbit synovial tissue PPAR-C. Chin J New Drugs Clin Remedies 2010;26:76-9","journal-title":"Chin J New Drugs Clin Remedies"},{"key":"e_1_3_2_129_1","first-page":"411","article-title":"Effect of extracts of paederia scandens on acute gouty arthritis induced by monosodium urate crystals in rats","volume":"19","author":"M Y","year":"2008","unstructured":"M Y, Yan HY, Lin M, et al. Effect of extracts of paederia scandens on acute gouty arthritis induced by monosodium urate crystals in rats. China Pharmacy 2008;19:411-14","journal-title":"China Pharmacy"},{"key":"e_1_3_2_130_1","first-page":"1393","article-title":"Study on anti-gout effects of ethanol extract of rhizoma smilax Chinae","volume":"9","author":"Deng J G","year":"2009","unstructured":"Deng J G, Zheng Z W, Huang L Q. Study on anti-gout effects of ethanol extract of rhizoma smilax Chinae. Sci Technol Eng 2009;9:1393-4","journal-title":"Sci Technol Eng"},{"key":"e_1_3_2_131_1","first-page":"13","article-title":"New method of sulfur chemical phade-analysis","volume":"34","author":"Li L","year":"2012","unstructured":"Li L, Lv M, Fang J D, et al. New method of sulfur chemical phade-analysis. J Wuhan Inst Technol 2012;34:13-15","journal-title":"J Wuhan Inst Technol"},{"key":"e_1_3_2_132_1","first-page":"12","article-title":"Effect of toona sinensis leaves extract against to gout","volume":"7","author":"Liang N","year":"2011","unstructured":"Liang N, Wang C L, Luo C, et al. Effect of toona sinensis leaves extract against to gout. Acad Periodical Farm Prod Process 2011;7:12-14","journal-title":"Acad Periodical Farm Prod Process"},{"key":"e_1_3_2_133_1","first-page":"4425","article-title":"Effects of different extracts of phyllanthus emblica on sodium urate-induced acute gouty arthritis in rats","volume":"22","author":"Cen ZF","year":"2011","unstructured":"Cen ZF, Zhang JP, Li HY, et al. Effects of different extracts of phyllanthus emblica on sodium urate-induced acute gouty arthritis in rats. China Pharmacy 2011;22:4425-7","journal-title":"China Pharmacy"},{"key":"e_1_3_2_134_1","first-page":"1","volume-title":"Study on the effective fractions from Prunus mume to treat hyperuricemia and gout and their mechanisms","author":"Xia ZD","year":"2010","unstructured":"Xia ZD. Study on the effective fractions from Prunus mume to treat hyperuricemia and gout and their mechanisms. Zhejiang University, Hangzhou; 2010. p. 1-211"},{"key":"e_1_3_2_135_1","first-page":"1","volume-title":"Study on traditional Chinese in Anti-gout","author":"Qian Y","year":"2011","unstructured":"Qian Y. Study on traditional Chinese in Anti-gout. Zhejiang University, Hangzhou; 2011. p. 1-107"},{"key":"e_1_3_2_136_1","first-page":"362","article-title":"The research of the total coumarin of cortex fraxini reducing the level of uric acid in hyperuricemia mice and its mechanism","volume":"37","author":"Cao RZ","year":"2010","unstructured":"Cao RZ, Zhang SY, Dai Y, et al. The research of the total coumarin of cortex fraxini reducing the level of uric acid in hyperuricemia mice and its mechanism. Liaoning J Tradit Chin Med 2010;37:362-3","journal-title":"Liaoning J Tradit Chin Med"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1185300"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-7843.2004.pto940506.x"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1142\/S0192415X12500723"},{"key":"e_1_3_2_140_1","unstructured":"Yang DJ Zhong GY Xu JH et al. The application of taxol and its derivatives in pharmaceutical. CN200810069882.1; 2008"},{"key":"e_1_3_2_141_1","unstructured":"Le KL Luo J. (-) (3- trihalomethyl methylphenoxy) (4-halophenyl) acetic acid derivatives application in the treatment of insulin resistance type 2 diabetes hyperlipidemia and hyperuricemia. CN00811290.8; 2000"},{"key":"e_1_3_2_142_1","unstructured":"Le KL Luo J. (-) (3- trihalomethyl methylphenoxy) (4-halophenyl) acetic acid derivatives application in the treatment of hyperuricemia. CN200410011657.4; 2000"}],"container-title":["Expert Opinion on Therapeutic Patents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543776.2014.895325","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:38:48Z","timestamp":1770928728000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543776.2014.895325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,7]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["10.1517\/13543776.2014.895325"],"URL":"https:\/\/doi.org\/10.1517\/13543776.2014.895325","relation":{},"ISSN":["1354-3776","1744-7674"],"issn-type":[{"value":"1354-3776","type":"print"},{"value":"1744-7674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,7]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ietp20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-03-07","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}